* Papers reported by KCLB using SNU cell line series [Updated on 2005-01-01]
  1. Park, J.-G., Kramer, B.S., Steinberg, S.M., Carmichael, J., Collins, J.M.,Minna, J.D., and Gazdar, A.F.: Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res., 47:5875, 1987. [PubMed]
  2. Park, J.-G., Oie, H.K., Sugarbaker P.H., Henslee, J.G., Chen, T.-R., Johnson, B.E., and Gazdar, A.F.: Characteristics of cell lines established from human colorectal carcinoma. Cancer Res., 47:6710, 1987. [PubMed]
  3. Carmichael, J., Park, J.-G., Degraff, W.G., Gamson, J., Gazdar, A.F., and Mitchell, J.G.: Radiation sensitivity and study of glutathione and related enzymes in human colorectal cancer cell lines. Eur. J Cancer Clin. Oncol., 24:1291, 1988. [PubMed]
  4. Park, J.-G., Collins, J.M., Gazdar, A.F., Allegra, C.J., Steinberg, S.M., Greene, G.F., and Kramer, B.S.: Enhancement of fluorinated pyrimidine- induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl. Cancer Inst., 80:1560, 1988. [PubMed]
  5. Park, J.-G., Kramer, B.S., Lai, S.L., Goldstein, L.J., and Gazdar, A.F.: Chemosensitivity patterns and expression of human multidrug resistance (MDR1) gene by human gastric and colorectal cell lines. J Natl. Cancer Inst. 82:193, 1990. [PubMed]
  6. Park, J.-G., Frucht, H., LaRocca, R.V., Bliss, D.P., Kurita, Y., Chen, T.-R., Henslee, J.G., Trepel, J.B., Jensen, R.T., Johnson, B.E., Bang,Y.J., Kim, J.P. and Gazdar, A.F.: Characteristics of cell lines established from human gastric carcinoma. Cancer Res., 50:2773, 1990. [PubMed]
  7. Gazdar, A.F., Park, J.-G., and Oie, H.K.: Characteristics of human colorectal cell lines established in defined and serum-supplemented media. In Moyer, M.P., and Poste, G. (eds.): Colon caner cell. Academic press., Orlando, FL, p.227-251, 1990. [PubMed]
  8. Mor, O., Messinger, Y., Rotman, G., Bar-Am, I., Ravia, Y., Eddy, R.L., Shows, T.B., Park, J.-G., Gazdar, A.F. and Shiloh, Y: Novel DNA sequence at chromosome 10q26 are amplified in human gastric carcinoma cell lines:molecular cloning by competitive DNA reassociation. Nucleic Acids Research 19:117-123, 1991. [PubMed]
  9. Kim, J.H., Takahashi, T., Chiba, I., Park, J.-G., Birrer, M.J., Roh, J.K., Lee, H.D., Kim, J.P., Minna, J.D., Gazdar, A.F.: Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl. Cancer Inst 83:938-943, 1991. [PubMed]
  10. Karnes, W.E., Walsh, J.H., Wu, S.V., Kim, R.S., Martin, M.G., Wong, H.C., Mendelsohn, J., Park, J.-G., Cuttitta, F.: Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effectsof receptor-blocking antibody. Gastroenterology 102:474-485, 1992. [PubMed]
  11. La Rocca, R.V., Park, J.-G., Danesi, R., Del Tacca, M., Steinberg, S.M., Gazdar, A.F.: Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines. Oncology 49:209-214, 1992. [PubMed]
  12. Gazdar, A.F., Kadoyama, C., Venzon, D., Park, J.-G., Tsai, C.-M., Linnoila, R.I., Mulshine, J.L., Ihde, D.C., Giaccone, G.: Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl. Cancer Inst. Monogr. 13:191, 1992. [PubMed]
  13. Frucht, H., Gazdar, A.F., Park, J.-G., Oie, H. and Jensen, R.T.: Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res., 52:1114, 1992. [PubMed]
  14. Park, J.-G., Lee, S.K., Hong, I.G., Kim, H.S., Lim, K.H., Choe, K.J., Kim, W.H., Kim, Y.I., Tsuruo, T., Michael M. and Gottesman, M.M.: MDR1 gene expression and its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J. Natl. Cancer Inst., 86:700, 1994. [PubMed]
  15. Park, K., Kim, S.J., Bang, Y.J., Park, J.-G., Kim, N.K., Roberts, A.B., and Sporn, M.B.: Genetic changes in the transforming growth factor (TGF- ) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGB- . Proc. Natl. Acad. Sci. USA, 91:8772, 1994. [PubMed]
  16. Park, J.-G., Lee, J.H., Kang, M.-S., Park, K.-J., Jeon, Y.-M., Lee, H.-J., Kwon, H.-S., Park, H.-S., Yeo, K.-S., Lee, K.-U., Kim, S.-T., Chung, J.-K., Hwang, Y.-J., Lee, H.-S., Kim, C.Y., Lee, Y.I., Chen, T.-R., Hay, R.J., Song, S.-S., Kim, W.-H., Kim, C.-W., and Kim, Y.-I.: Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer., 62:276, 1995. [PubMed]
  17. Myeroff, L.L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K.R., Orth, K., Mathis, M., Kinzler, K.W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H.Y., Park., J.-G., Lynch, H.T., Roberts, A.B., Vogelstein, B., and Markowitz, S.D.: A transforming growth factor receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55:5545, 1995. [PubMed]
  18. Park, J.-G., and Gazdar, A.F.: Biology of colorectal and gastric cancer cell lines. J. Cell. Biochem. (Suppl.), 24:131, 1996. [PubMed]
  19. Kim, S.-O., Park, J.-G., and Lee, Y. I.: Increased expression of the insulin-like growth factor I receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res., 56:3831, 1996. [PubMed]
  20. Kang, M.-S., Lee H.-J., Lee, J.-H., Ku, J.-L., Lee, K.P., Kelley, M.J., Won, Y.-J., Kim, S.-T., and Park, J.-G.: Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA. Int. J. Cancer., 67:898, 1996. [PubMed]
  21. Park, J.-G., Yang, H.-K., Kim, W.H., Chung, J.-K., Kang, M.-S., Lee, J.-H., Oh, J.H., Park, H.-S., Yeo, K.-S., Kang, S.H., Song, S.-Y., Kang, Y.K., Bang, Y.-J., Kim, Y.I., and Kim, J.-P.: Establishment and characterization of human gastric carcinoma cell lines. Int. J. Cancer, 70:433, 1997. [PubMed]
  22. Lim, K.-H., Kim, H.-S., Yang, Y.-M., Lee, S.-D., Kim, W.-B., Yang, J., and Park J.-G. : Cellular uptake and antitumor activity of the new anthracycline analog DA-125 in human cancer cell lines. Cancer Chemother. Pharmacol., 40:23, 1997. [PubMed]
  23. Ku,J.-L., Kim,W.-H., Park,H.-S., Kang,S.-B., and Park,J.-G. : Establishment and characterization of 12 uterine cervical-carcinoma cell lines : Common sequence variation in the E7 gene of HPV-16-positive cell lines. Int. J. Cancer., 72:313, 1997. [PubMed]
  24. Yuan,Y., Kim,W.-H., Han,H.S., Lee,J.-H., Park,H.-S., Chung,J.-K., Kang,S.-B., and Park,J.-G. : Establishment and characterization of human ovarian carcinoma cell lines. Gynecol. Oncol., 66:378, 1997. [PubMed]
  25. Yuan,Y., Kim,W.-H., Han,H.S., Lee,J.-H., Park,H.-S., Chung,J.-K., Kang,S.-B., and Park,J.-G. : Establishment and characterization of cell lines derived from uterine malignant mixed M llerian tumor. Gynecol. Oncol., 66:464, 1997. [PubMed]
  26. Kang,M.-S., Kim,H.-S., Han,J.-A., Park,S.-C., Kim,W.-B., and Park,J.-G. :Characteristics of human gastric carcinoma cell lines with induced multidrug resistance. Anticancer Res., 17:3531, 1997. [PubMed]
  27. Park,J.-G.: Biology of colorectal cancer cells. In: The 9th Annual Colorectal Disease in 1998. Ft. Lauderdale, Cleveland Clinic Florida, pp471-486, 1998. [PubMed]
  28. Lee,W.-K., Kim,S.-M., Sim,Y.-S., Cho,S.-G., Park,S.-H., Kim,C.-W., and Park,J.-G.: B-Lymphoblastoid cell lines from cancer patients. In Vitro Cell. Dev. Biol., 34:97-100, 1998. [PubMed]
  29. Shin,K.-H., Han,H.-J., and Park,J.-G. : Growth suppression mediated by transfection of wild-type hMLH1 in human cancer cells expressing endogenous truncated hMLH1 protein. Int. J. Oncol., 12:609, 1998. [PubMed]
  30. Shin,K.H., Yang,Y.M., Park,J.-G. : Absence or decreased level of the hMLH1 protein in human gastric carcinoma cell lines. J. Cancer Res. Clin. Oncol., 124:421-426, 1998. [PubMed]
  31. Kim,H.S., Lee.B.L., Bae,S.I., Kim,Y.I., Park,J.-G., Kleinman,HK, and Kim,W.-H.: Differentiation of a colon cancer cell line on a reconstituted basement membrane in vitro. Int. J. Exp. Pathol., 79:443-451, 1998 [PubMed]
  32. Oh,J.H., Ku,J.-L., Yoon,K.-A., Kwon,H.-J., Kim,W.-H., Park,H.-S., Yeo,K.-S., Song, S.-Y., Chung,J.-K., and Park,J.-G.: Establishment and characterization of 12 human colorectal carcinoma cell lines. Int. J. Cancer, 81:902-910, 1999. [PubMed]
  33. Ku,J.-L., Kim,W.-H., Lee,J.-H., Park,H.-S., Kim,K.-H., Sung,M.-H., and Park,J.-G. : Establishment and characterization of human laryngeal carcinoma cell lines. Laryngoscope, 109:976-982, 1999. [PubMed]
  34. Lee,J.-H., Ku,J.-L., Park,Y.-J., Lee,K.-U., Kim,W.-H., and Park,J.-G. : Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA., W. J. G., 5:289-295, 1999. [PubMed]
  35. Ku,J.-L., Yoon,K.-A., Kim,D.-Y., and Park,J.-G. : Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines., European J. of Cancer, 35:1724-1729, 1999. [PubMed]
  36. Shin,K.-H., Ku,J.-L., Kim,W.-H., Lee,S.-E., Lee,C.W., Kim,S.-W., and Park.,J.-G. : Establishment and characterization of 7 human renal cell carcinoma cell lines. BJU Int., 85:130-137, 2000. [PubMed]
  37. Shin,K.-H., and Park,J.-G. : Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair genes hMSH2 and hMLH1. European J. Cancer, 36:925-931, 2000. [PubMed]
  38. Jang,J.H, Shin,K.H, Park,Y.J, Lee RJ, McKeehan,WL, Park,J-G. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Research, 60:4049-4052, 2000. [PubMed]
  39. Bae SI, Park J-G, Kim YI, Kim WH. Genetic alterations in gastric cancer cell lines and their original tissues. Int J Cancer. 874:512-516, 2000. [PubMed]
  40. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park J-G, Kim SJ, Markowitz S. E-cadherin gene promoter methylation as the second genetic hit in hereditary gastric cancer. Nature Genet., 2000, 26(1):16-17. [PubMed]
  41. Fukuda Y, Kurihara N, Imoto I, Yasui K, Yoshida M, Yanagihara K, Park JG, Nakamura Y, Inazawa J. CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines. Genes Chromosomes Cancer. 2000 Dec;29(4):315-24. [PubMed]
  42. Jang JH, Shin KH, Park JG. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res. 2001 May 1;61(9):3541-3. [PubMed]
  43. Hong KM, Jang SJ, Kong G, Song KY, Park JG, Kim DJ, Chung JH, Lee JH, Paik MK, Chung HK. A novel tumor-associated mucin of gastrointestinal carcinoma. J Cancer Res Clin Oncol. 2001 Sep;127(9):551-8. [PubMed]
  44. Shin KH, Park YJ, Park JG. PTEN gene mutations in colorectal cancers displaying microsatellite instability. Cancer Lett. 2001 Dec 28;174(2):189-94. [PubMed]
  45. Shin KH, Choe G, Park YJ, Jang JH, Jung HW, Park JG. Establishment and characterization of nine human brain tumor cell lines. In Vitro Cell Dev Biol Anim. 2001 Nov-Dec;37(10):625-8. [PubMed]
  46. Park JG. SNU cell lines and their application for cancer research. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:89-98. Review. [PubMed]
  47. Shin JH, Chung J, Kim HO, Kim YH, Hur YM, Rhim JH, Chung HK, Park SC, Park JG, Yang HK.  Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs. Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:137-44. [PubMed]
  48. Ku JL, Yoon KA, Kim WH, Jang Y, Suh KS, Kim SW, Park YH, Park JG. Establishment and characterization of four human pancreatic carcinoma cell linesGenetic alterations in the TGFBR2 gene but not in the MADH4 gene. Cell Tissue Res. 2002 May;308(2):205-14. [PubMed]
  49. Ku J.-L,, Yoon KA, Kim IJ, Kim WH, Jang JY, Suh KS, Kim SW, Park YH, Hwang JH, Yoon YB, and Park JG : Establishment and characterization of 6 human biliary tract cancer cell lines. Brit J Cancer, 87:187-193, 2002. [PubMed]
  50. Hansel DE, Rahman A, Hidalgo M, Thuluvath, PJ, Lillemoe, KD, Shulick, R, Ku JL, Park JG, Miyazaki, K, Ashfaq, R, Wistuba, II, Varma, R, Hawthorne, L, Geradts, J, Argani, P, and Maitra, A : Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol, 163: 217-229, 2003. [PubMed]
  51. Kim IJ, Kang, HC, Park, JH, Shin, Y, Ku JL, Lim, SB, Park, SY, Jung, SY, Kim, HK, and Park JG : Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin Cancer Res, 9: 2920-2925, 2003. [PubMed]
  52. Kim IJ, Park, JH, Kang, HC, Shin, Y, Park, HW, Park, HR, Ku JL, Lim, SB, and Park JG : Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet, 114: 118-120, 2003. [PubMed]
  53. Shin JH, Shin, YK, Ku JL, Jeong, SY, Hong, SH, Park, SY, Kim, WH, and Park JG : Mutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability. J Med Genet, 40: 364-367, 2003. [PubMed]
  54. Yoon KA, Ku JL, Yang, JO, and Park JG : Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines. Int J Mol Med, 11: 343-348, 2003. [PubMed]
  55. Kang HC, Kim IJ, Park, JH, Shin, Y, Ku JL, Jung, MS, Yoo, BC, Kim, HK, and Park JG : Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res, 10: 272-284, 2004. [PubMed]
  56. Kang HC, Kim, IJ, Park, JH, Shin, Y, Park, HW, Ku JL, Yang, HK, Lee, KU, Choe, KJ, and Park JG : Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers. Oncol Rep, 12: 129-133, 2004. [PubMed]
  57. Kang YH, Lee, E, Choi, MK, Ku JL, Kim, SH, Park, YG, and Lim SJ : Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer, 112: 385, 2004. [PubMed]
  58. Kim IJ, Ku JL, Kang, HC, Park, JH, Yoon, KA, Shin, Y, Park, HW, Jang, SG, Lim, SK, Han, SY, Shin, YK, Lee, MR, Jeong, SY, Shin, HR, Lee, JS, Kim, WH, and Park JG : Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Hum Genet, 2004. [PubMed]
  59. Ku JL, Kang, SB, Shin, YK, Kang, HC, Hong, SH, Kim, IJ, Shin, JH, Han, IO, and Park JG : Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene, 23: 6736-6742, 2004. [PubMed]
  60. Oh ST, Seo, JS, Moon, UY, Kang, KH, Shin, DJ, Yoon, SK, Kim, WH, Park JG, and Lee, SK : A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology, 320: 330-336, 2004. [PubMed]
  61. Park JG, Ku JL, and Park, SY : Isolation and culture of colon cancer cell lines. Methods Mol Med, 88: 79-92, 2004. [PubMed]
  62. Park JG, Ku JL, and Park, SY : Isolation and culture of renal cancer cell lines. Methods Mol Med, 88: 111-119, 2004. [PubMed]
  63. Park JG, Ku JL, Kim HS, Park SY, Rutten MJ : Culture of normal and malignant gastric epithelium. In: F. R. Pfragner R (ed.), Culture of human tumor cells, pp. 23-66. Hoboken: John Wiley & Sons, 2004.
  64. Park JH, Kim, IJ, Kang, HC, Shin, Y, Park, HW, Jang, SG, Ku JL, Lim, SB, Jeong, SY, and Park JG : Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization. Clin Chem, 50: 1688-1691, 2004. [PubMed]
  65. Shin Y, Kim, IJ, Kang, HC, Park, JH, Park, HR, Park, HW, Park, MA, Lee, JS, Yoon, KA, Ku JL, and Park JG : The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis, 25: 895-899, 2004. [PubMed]
  66. Shin Y, Kim, IJ, Kang, HC, Park, JH, Park, HW, Jang, SG, Lee, MR, Jeong, SY, Chang, HJ, Ku JL, and Park JG : A functional polymorphism (-347 G->GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis, 2004. [PubMed]
  67. Yoo BC, Jeon, E, Hong, SH, Shin, YK, Chang, HJ, and Park JG : Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Clin Cancer Res, 10: 4176-4184, 2004. [PubMed]
  68. Yoo BC, Ku JL, Hong, SH, Shin, YK, Park, SY, Kim, HK, and Park JG : Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines. Int J Cancer, 108: 532-539, 2004. [PubMed]
 
* Papers reported by outside researchers using SNU cell line series [Updated on 2005-01-01]
  1. Grem JL, Allegra CJ. Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells. J Natl Cancer Inst. 1989 Sep 20;81(18):1413-7. [PubMed]
  2. Tsai CM, Gazdar AF, Perng RP, Kramer BS. Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines. Int J Cancer. 1991 Feb 1;47(3):401-7. [PubMed]
  3. Grem JL, Allegra CJ. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine. Biochem Pharmacol. 1991 Jul 5;42(2):409-18. [PubMed]
  4. Lee LK, Allegra CJ, Trepel JB, Grem JL. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells. Biochem Pharmacol. 1992 Apr 1;43(7):1587-99. [PubMed]
  5. Bar-Am I, Mor O, Yeger H, Shiloh Y, Avivi L. Detection of amplified DNA sequences in human tumor cell lines by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1992 Jun;4(4):314-20. [PubMed]
  6. Mor O, Ranzani GN, Ravia Y, Rotman G, Gutman M, Manor A, Amadori D, Houldsworth J, Hollstein M, Schwab M, et al. DNA amplification in human gastric carcinomas. Cancer Genet Cytogenet. 1993 Feb;65(2):111-4. [PubMed]
  7. Bae CD, Park SE, Seong YS, Kimm SW, Park JB, Park JB. The mechanism of c-erbB-2 gene product increase in stomach cancer cell lines. J Korean Med Sci. 1993 Apr;8(2):153-9. [PubMed]
  8. Shibata J, Aiba K, Shibata H, Minowa S, Horikoshi N. Detection of thymidylate synthase mRNA in 5-fluorouracil resistant human colon adenocarcinoma cells]. Gan To Kagaku Ryoho. 1994 Aug;21(10):1613-8. Japanese. [PubMed]
  9. Grem JL, Voeller DM, Geoffroy F, Horak E, Johnston PG, Allegra CJ. Determinants of trimetrexate lethality in human colon cancer cells. Br J Cancer. 1994 Dec;70(6):1075-84. [PubMed]
  10. Rand A, Glenn KS, Alvares CP, White MB, Thibodeau SM, Karnes WE Jr. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles. Cancer Lett. 1996 Jan 2;98(2):183-91. [PubMed]
  11. Buell JF, Reed E, Lee KB, Parker RJ, Venzon DJ, Amikura K, Arnold S, Fraker DL, Alexander HR. Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells. Ann Surg Oncol. 1997 Mar;4(2):141-8. [PubMed]
  12. Park IK, Kim BJ, Goh YJ, Lyu MA, Park CG, Hwang ES, Kook YH. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity. Int J Cancer. 1997 May 29;71(5):867-73. [PubMed]
  13. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 1997 Jul 15;57(14):2856-9. [PubMed]
  14. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol. 1997 Jul;12(7):473-80. [PubMed]  
  15. Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM Jr. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. Surgery. 1997 Aug;122(2):187-94; discussion 194-5. [PubMed]
  16. Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R, Han IS. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett. 1997 Dec 9;120(2):235-41. [PubMed]
  17. Park IC, Park MJ, Lee SH, Choe TB, Jang JJ, Hong SI. Increased susceptibility of the c-Myc overexpressing cell line, SNU-16, to TNF-alpha. Cancer Lett. 1998 Mar 13;125(1-2):17-23. [PubMed]
  18. Shibata J, Aiba K, Shibata H, Minowa S, Horikoshi N. Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR. Anticancer Res. 1998 May-Jun;18(3A):1457-63. [PubMed]
  19. Chang SH, Kim SH, Lee WK, Kim HJ, Choi SH, Park JH, Jang HS, Chung GH, Kwon TH, Kim DH, Yang MS, Jang YS. Protein, Nucleotide Cloning and analysis of the Epstein-Barr virus glycoprotein 350 genes. Mol Cells. 1998 Oct 31;8(5):585-93. [PubMed]
  20. Yoo YD, Park JK, Choi JY, Lee KH, Kang YK, Kim CS, Shin SW, Kim YH, Kim JS. CDK4 down-regulation induced by paclitaxel is associated with G1 arrest in gastric cancer cells. Clin Cancer Res. 1998 Dec;4(12):3063-8. [PubMed]
  21. Park YS, Kim YH, Kim SK, Choi SJ. A new antitumor agent: methyl sulfonium perchlorate of echinomycin. Bioorg Med Chem Lett. 1998 Apr 7;8(7):731-4. [PubMed]
  22. Hara T, Ooi A, Kobayashi M, Mai M, Yanagihara K, Nakanishi I. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest. 1998 Sep;78(9):1143-53. [PubMed]
  23. Ahn CM, Kim SK, Han JL. Synthesis of 6-aziridinylbenzimidazole derivatives and their in vitro antitumor activities. Arch Pharm Res. 1998 Oct;21(5):599-609. [PubMed]
  24. Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, Jeong JM, Lee DS, Jang JJ, Lee MC. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. J Nucl Med. 1999 Feb;40(2):339-46. [PubMed]
  25. Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells. Oncogene. 1999 Apr 1;18(13):2213-9. [PubMed]
  26. Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim SJ. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells. Br J Cancer. 1999 Jun;80(8):1144-9. [PubMed]
  27. Park HJ, Lee MS, Lee KT, Sohn IC, Han YN, Miyamoto K. Studies on constituents with cytotoxic activity from the stem bark of Syringa velutina. Chem Pharm Bull (Tokyo). 1999 Jul;47(7):1029-31. [PubMed]
  28. Okabe S, Ochiai Y, Aida M, Park K, Kim SJ, Nomura T, Suganuma M, Fujiki H. Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res. 1999 Jul;90(7):733-9. [PubMed]
  29. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer. 1999 Aug 15;86(4):559-65. [PubMed]
  30. Shin EC, Shin JS, Park JH, Kim H, Kim SJ. Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand. Int J Cancer. 1999 Aug 12;82(4):587-91. [PubMed]
  31. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer. 1999 Aug 20;84(4):400-3. [PubMed]
  32. Weller SG, Klein IK, Penington RC, Karnes WE Jr. Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells. Gastroenterology. 1999 Oct;117(4):848-57. [PubMed]
  33. Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, Lee HS, Kim NK, Kim SJ. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene. 1999 Dec 2;18(51):7280-6. [PubMed]
  34. Mans DR, Grivicich I, Peters GJ, Schwartsmann G. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines. Eur J Cancer. 1999 Dec;35(13):1851-61. [PubMed]
  35. Park SH, Park SY, Kim DW, Chun YH. Chromosomal aberrations in ovarian malignant brenner tumor cell line using chromosome painting. Cancer Genet Cytogenet. 2000 Apr 15;118(2):151-3. [PubMed]
  36. Shin JY, Kim HS, Park J, Park JB, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res. 2000 Jan 15;60(2):262-5. [PubMed]
  37. Chun YH, Kil JI, Suh YS, Kim SH, Kim H, Park SH. Characterization of chromosomal aberrations in human gastric carcinoma cell lines using chromosome painting. Cancer Genet Cytogenet. 2000 May;119(1):18-25. [PubMed]
  38. Yang Z, Liu S, Chen X, Chen H, Huang M, Zheng J. Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid. Cancer Res. 2000 Feb 1;60(3):505-9. [PubMed]
  39. Song JJ, Lee H, Kim E, Kim YS, Yoo NC, Roh JK, Kim BS, Kim J. Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells. Cancer Lett. 2000 Aug 31;157(1):1-7. [PubMed]
  40. Leung WK, Kim JJ, Wu L, Sepulveda JL, Sepulveda AR. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J Biol Chem. 2000 May 26;275(21):15728-32. [PubMed]
  41. Lee KT, Sohn IC, Park HJ, Kim DW, Jung GO, Park KY. Essential moiety for antimutagenic and cytotoxic activity of hederagenin monodesmosides and bisdesmosides isolated from the stem bark of Kalopanax pictus. Planta Med. 2000 May;66(4):329-32. [PubMed]
  42. Park IC, Park MJ, Choe TB, Jang JJ, Hong SI, Lee SH. TNF-alpha induces apoptosis mediated by AEBSF-sensitive serine protease(s) that may involve upstream caspase-3/CPP32 protease activation in a human gastric cancer cell line. Int J Oncol. 2000 Jun;16(6):1243-8. [PubMed]
  43. Kang SH, Choi HH, Kim SG, Jong HS, Kim NK, Kim SJ, Bang YJ. Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines. Int J Cancer. 2000 Jun 1;86(5):632-5. [PubMed]
  44. Atienza C Jr, Elliott MJ, Dong YB, Yang HL, Stilwell A, Liu TJ, McMasters KM. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Int J Mol Med. 2000 Jul;6(1):55-63. [PubMed]
  45. Ahn CM, Tak JA, Choi SJ. Synthesis and in vitro antitumor activity of 2-alkyl, 2-aryl, and 2-piperazinyl benzimidazole-4,7-dione derivatives. Arch Pharm Res. 2000 Aug;23(4):288-301. [PubMed]
  46. Park IC, Park MJ, Rhee CH, Lee JI, Choe TB, Jang JJ, Lee SH, Hong SI. Protein kinase C activation by PMA rapidly induces apoptosis through caspase-3/CPP32 and serine protease(s) in a gastric cancer cell line. Int J Oncol. 2001 May;18(5):1077-83. [PubMed]
  47. Shin EC, Shin WC, Choi Y, Kim H, Park JH, Kim SJ. Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells. Cancer Immunol Immunother. 2001 Mar;50(1):23-30. [PubMed]
  48. Quasney ME, Carter LC, Oxford C, Watkins SM, Gershwin ME, German JB. Inhibition of proliferation and induction of apoptosis in SNU-1 human gastric cancer cells by the plant sulfolipid, sulfoquinovosyldiacylglycerol. J Nutr Biochem. 2001 May;12(5):310-315. [PubMed]
  49. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer. 2001 Mar 20;95(2):108-13. [PubMed]
  50. Kim SG, Kim SN, Jong HS, Kim NK, Hong SH, Kim SJ, Bang YJ. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Oncogene 2001 Mar 8;20(10):1254-65. [PubMed]
  51. Tian Q, Miller EG, Ahmad H, Tang L, Patil BS. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 2001;40(2):180-4. [PubMed]
  52. Bae CD, Juhnn YS, Park JB. Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells. Exp Mol Med 2001 Mar 31;33(1):15-9. [PubMed]
  53. Yu S, Lee M, Shin S, Park J. Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840. J Cell Biochem 2001;82(3):445-51. [PubMed]
  54. Nam KS, Jo YS, Kim YH, Hyun JW, Kim HW. Cytotoxic activities of acetoxyscirpenediol and ergosterol peroxide from Paecilomyces tenuipes. Life Sci 2001 Jun 1;69(2):229-37. [PubMed]
  55. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 2001 Jul 15;93(2):262-8. [PubMed]
  56. Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK, Bang YJ. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. Cancer Res 2001 Aug 1;61(15):5956. [PubMed]
  57. Lee W, Hwang YH, Lee SK, Subramanian C, Robertson ES. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A. J Virol 2001 Sep;75(18):8556-68. [PubMed]
  58. Mayer B, Klement G, Kaneko M, Man S, Jothy S, Rak J, Kerbel RS. Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 2001 Oct;121(4):839-52. [PubMed]
  59. Lee TB, Min YD, Lim SC, Kim KJ, Jeon HJ, Choi SM, Choi CH. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells. J Gastroenterol Hepatol 2002 Jan;17(1):32-38. [PubMed]
  60. Kang YH, Bae SI, Kim WH. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. J Cancer Res Clin Oncol 2002 Mar;128(3):119-24. [PubMed]
  61. Iizaka M, Furukawa Y, Tsunoda T, Akashi H, Ogawa M, Nakamura Y. Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun 2002 Mar 29;292(2):498-512. [PubMed]
  62. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002 Apr 5;109(1):113-24. [PubMed]
  63. Holian O, Wahid S, Atten MJ, Attar BM. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physiol Gastrointest Liver Physiol 2002 May;282(5):G809-16. [PubMed]
  64. Tian Q, Miller EG, Ahmad H, Tang L, Patil BS. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer. 2001;40(2):180-4. [PubMed]
  65. Kim HH, Kwak C, Jeong BC, Kim SW. Effect of oxalate on the growth of renal tubular epithelial cells. J Endourol. 2002 May;16(4):261-4. [PubMed]
  66. Bae SI, Lee HS, Kim SH, Kim WH. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer. 2002 Jun 17;86(12):1888-92. [PubMed]
  67. Kim H, Lim JW, Seo JY, Kim KH. Oxidant-sensitive transcription factor and cyclooxygenase-2 by Helicobacter pylori stimulation in human gastric cancer cells. J Environ Pathol Toxicol Oncol. 2002;21(2):121-9. [PubMed]
  68. Min JJ, Chung JK, Lee YJ, Shin JH, Yeo JS, Jeong JM, Lee DS, Bom HS, Lee MC. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol. 2002 Jul;29(5):537-45. [PubMed]
  69. Kim HR, Jeong JA, Park CH, Lee SK, Lee WK, Jang YS. A role for cell cycle proteins in the serum-starvation resistance of Epstein-Barr virus immortalized B lymphocytes. Biochem Cell Biol. 2002;80(4):407-13. [PubMed]
  70. Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson DA. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene. 2002 Sep 26;21(43):6598-605. [PubMed]
  71. Cheng K, Chen Y, Zimniak P, Raufman J, Xiao Y, Frucht H. Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line.Biochim Biophys Acta. 2002 Oct 9;1588(1):48. [PubMed]
  72. Kim, JM, Kim, JS, Jung, HC, Song, IS, and Kim, CY Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interferon-gamma in polarized nitric oxide secretion. Helicobacter, 7: 116-128, 2002. [PubMed]
  73. Sakakura, C, Hagiwara, A, Nakanishi, M, Shimomura, K, Takagi, T, Yasuoka, R, Fujita, Y, Abe, T, Ichikawa, Y, Takahashi, S, Ishikawa, T, Nishizuka, I, Morita, T, Shimada, H, Okazaki, Y, Hayashizaki, Y, and Yamagishi, H Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer, 87: 1153-1161, 2002. [PubMed]
  74. Sakakura, C, Simomura, K, Shuichi, K, Nakase, Y, Fukuda, K, Takagi, T, Hagiwara, A, Ichikawa, Y, Nishizuka, I, Ishikawa, T, Okazaki, Y, and Yamagishi, H [Screening of novel biomarkers for the detection of intraperitoneally disseminated cancer cells using human cDNA microarray]. Gan To Kagaku Ryoho, 29: 2271-2274, 2002. [PubMed]
  75. Shin, EY, Ma, EK, Kim, CK, Kwak, SJ, and Kim, EG Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell. J Cancer Res Clin Oncol, 128: 596-602, 2002. [PubMed]
  76. Zhang, H, Wu, J, Meng, L, and Shou, CC Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol, 8: 994-998, 2002. [PubMed]
  77. Baek, WK, Kim, D, Jung, N, Yi, YW, Kim, JM, Cha, SD, Bae, I, and Cho, CH Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol, 188: 634-639, 2003. [PubMed]
  78. Campbell, M, Qu, S, Wells, S, Sugandha, H, and Jensen, RA An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression. Cancer Gene Ther, 10: 559-570, 2003. [PubMed]
  79. Cho, JW, Jeong, YW, Han, SW, Park, JB, Jang, BC, Baek, WK, Kwon, TK, Park, JW, Kim, SP, Suh, MH, and Suh, SI Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression. Liver Int, 23: 194-200, 2003. [PubMed]
  80. Cho, YG, Nam, SW, Kim, TY, Kim, YS, Kim, CJ, Park, JY, Lee, JH, Kim, HS, Lee, JW, Park, CH, Song, YH, Lee, SH, Yoo, NJ, Lee, JY, and Park, WS Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. Apmis, 111: 539-545, 2003. [PubMed]
  81. Choi, CH Cloning and functional study of a novel human metallothionein-I isoform induced by paraquat. Biochem Biophys Res Commun, 304: 236-240, 2003. [PubMed]
  82. Chung, PS, Kim, HG, Rhee, CK, and Saxton, RE Anticancer effect of combined intratumor cisplatin injection and interstitial KTP laser therapy on xenografted squamous cell carcinoma. J Clin Laser Med Surg, 21: 23-27, 2003. [PubMed]
  83. Ferber, MJ, Montoya, DP, Yu, C, Aderca, I, McGee, A, Thorland, EC, Nagorney, DM, Gostout, BS, Burgart, LJ, Boix, L, Bruix, J, McMahon, BJ, Cheung, TH, Chung, TK, Wong, YF, Smith, DI, and Roberts, LR Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene, 22: 3813-3820, 2003. [PubMed]
  84. Han, SH, Jeon, JH, Ju, HR, Jung, U, Kim, KY, Yoo, HS, Lee, YH, Song, KS, Hwang, HM, Na, YS, Yang, Y, Lee, KN, and Choi, I VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene, 22: 4035-4046, 2003. [PubMed]
  85. Huang, JZ, Xia, SS, Ye, QF, Jiang, HY, and Chen, ZH Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells. World J Gastroenterol, 9: 84-88, 2003. [PubMed]
  86. Hwang, HJ, Kim, GJ, Lee, GB, Oh, JT, Chun, YH, and Park, SH A comprehensive karyotypic analysis on Korean hepatocellular carcinoma cell lines by cross-species color banding and comparative genomic hybridization. Cancer Genet Cytogenet, 141: 128-137, 2003. [PubMed]
  87. Hwang, IR, Hsu, PI, Peterson, LE, Gutierrez, O, Kim, JG, Graham, DY, and Yamaoka, Y Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter, 8: 142-148, 2003. [PubMed]
  88. Jeong, JH, Park, JS, Moon, B, Kim, MC, Kim, JK, Lee, S, Suh, H, Kim, ND, Kim, JM, Park, YC, and Yoo, YH Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1. Ann N Y Acad Sci, 1010: 171-177, 2003. [PubMed]
  89. Jeong, YW, Kim, KS, Oh, JY, Park, JC, Baek, WK, Suh, SI, Suh, MH, Lee, JC, and Cho, JW Exogenous wild-type p16INK4A gene induces delayed cell proliferation and promotes chemosensitivity through decreased pRB and increased E2F-1 expressions. Int J Mol Med, 12: 61-65, 2003. [PubMed]
  90. Ju, HR, Jung, U, Sonn, CH, Yoon, SR, Jeon, JH, Yang, Y, Lee, KN, and Choi, I Aberrant signaling of TGF-beta1 by the mutant Smad4 in gastric cancer cells. Cancer Lett, 196: 197-206, 2003. [PubMed]
  91. Kim, JM, Kim, JS, Jung, HC, Oh, YK, Kim, N, and Song, IS Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells. Helicobacter, 8: 542-553, 2003. [PubMed]
  92. Kim, TY, Jong, HS, Song, SH, Dimtchev, A, Jeong, SJ, Lee, JW, Kim, NK, Jung, M, and Bang, YJ Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene, 22: 3943-3951, 2003. [PubMed]
  93. Koh, TY, Park, SW, Park, KH, Lee, SG, Seol, JG, Lee, DW, Lee, CT, Heo, DS, Kim, KH, and Sung, MW Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines. Head Neck, 25: 44-49, 2003. [PubMed]
  94. Lee, DH, Yang, Y, Lee, SJ, Kim, KY, Koo, TH, Shin, SM, Song, KS, Lee, YH, Kim, YJ, Lee, JJ, Choi, I, and Lee, JH Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res, 63: 4648-4655, 2003. [PubMed]
  95. Lee, H, Lee, SI, Cho, J, Choi, SU, and Yang, SI Synthesis and in vitro evaluation of 1,8-diazaanthraquinones bearing 3-dialkylaminomethyl or 3-(N-alkyl- or N-aryl)carbamoyloxymethyl substituent. Eur J Med Chem, 38: 695-702, 2003. [PubMed]
  96. Nam, SY, Jung, GA, Hur, GC, Chung, HY, Kim, WH, Seol, DW, and Lee, BL Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers. Cancer Sci, 94: 1066-1073, 2003. [PubMed]
  97. Park, HJ, Lee, HJ, Lee, EJ, Hwang, HJ, Shin, SH, Suh, ME, Kim, C, Kim, HJ, Seo, EK, and Lee, SK Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs. Biosci Biotechnol Biochem, 67: 1944-1949, 2003. [PubMed]
  98. Park, SW, Lee, SG, Song, SH, Heo, DS, Park, BJ, Lee, DW, Kim, KH, and Sung, MW The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int J Cancer, 107: 729-738, 2003. [PubMed]
  99. Schneider, BG, Rha, SY, Chung, HC, Bravo, JC, Mera, R, Torres, JC, Plaisance, KT, Jr., Schlegel, R, McBride, CM, Reveles, XT, and Leach, RJ Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Mol Pathol, 56: 141-149, 2003. [PubMed]
  100. Shin, BA, Yoo, HG, Kim, HS, Kim, MH, Hwang, YS, Chay, KO, Lee, KY, Ahn, BW, and Jung, YD P38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells. Oncol Rep, 10: 1467-1471, 2003. [PubMed]
  101. Sung, MW, Roh, JL, Park, BJ, Park, SW, Kwon, TK, Lee, SJ, and Kim, KH Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope, 113: 1059-1063, 2003. [PubMed]
  102. Zhou, C, Smith, JL, and Liu, J Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1. Oncogene, 22: 2396-2404, 2003. [PubMed]
  103. Baykal, A, Rosen, D, Zhou, C, Liu, J, and Sahin, AA Telomerase in breast cancer: a critical evaluation. Adv Anat Pathol, 11: 262-268, 2004. [PubMed]
  104. Choi, MC, Jong, HS, Kim, TY, Song, SH, Lee, DS, Lee, JW, Kim, NK, and Bang, YJ AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene, 23: 7095-7103, 2004. [PubMed]
  105. Chun, E and Lee, KY Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun, 315: 771-779, 2004. [PubMed]
  106. Chung, Y, Shin, YK, Zhan, CG, Lee, S, and Cho, H Synthesis and evaluation of antitumor activity of 2- and 6-[(1,3-benzothiazol-2-yl)aminomethyl]-5,8-dimethoxy-1,4-naphthoquinone derivatives. Arch Pharm Res, 27: 893-900, 2004. [PubMed]
  107. Han, SU, Kim, HT, Seong do, H, Kim, YS, Park, YS, Bang, YJ, Yang, HK, and Kim, SJ Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene, 23: 1333-1341, 2004. [PubMed]
  108. Jang, TJ, Kang, HJ, Kim, JR, and Yang, CH Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis, 25: 1853-1858, 2004. [PubMed]
  109. Kim, SG, Jong, HS, Kim, TY, Lee, JW, Kim, NK, Hong, SH, and Bang, YJ Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell, 15: 420-434, 2004. [PubMed]
  110. Lee, HS, Park, MH, Yang, SJ, Jung, HY, Byun, SS, Lee, DS, Yoo, HS, Yeom, YI, and Seo, SB Gene Expression Analysis in Human Gastric Cancer Cell Line Treated with Trichostatin A and S-Adenosyl-L-homocysteine Using cDNA Microarray. Biol Pharm Bull, 27: 1497-1503, 2004. [PubMed]
  111. Nagayama, S, Iiizumi, M, Katagiri, T, Toguchida, J, and Nakamura, Y Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas. Oncogene, 23: 5551-5557, 2004. [PubMed]
  112. Park, CH, Kim, HR, Kim, J, Jang, SH, Lee, KY, Chung, GH, and Jang, YS Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes. J Cell Biochem, 91: 777-785, 2004. [PubMed]
  113. Park, J, Song, SH, Kim, TY, Choi, MC, Jong, HS, Lee, JW, Kim, NK, Kim, WH, and Bang, YJ Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene, 23: 3474-3480, 2004. [PubMed]
  114. Park, SS, Eom, YW, Kim, EH, Lee, JH, Min do, S, Kim, S, Kim, SJ, and Choi, KS Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosis. Oncogene, 23: 6272-6281, 2004. [PubMed]
  115. Rabenau, KE, O'Toole, JM, Bassi, R, Kotanides, H, Witte, L, Ludwig, DL, and Pereira, DS DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene, 23: 5056-5067, 2004. [PubMed]
  116. Ryu, EK, Choe, YS, Byun, SS, Lee, KH, Chi, DY, Choi, Y, and Kim, BT Synthesis of radioiodine labeled dibenzyl disulfide for evaluation of tumor cell uptake. Bioorg Med Chem, 12: 859-864, 2004. [PubMed]
  117. Seo, BR, Yoo, CB, Park, HJ, Choi, JW, Seo, K, Choi, SK, and Lee, KT Saucernetin-8 Isolated from Saururus chinensis Induced the Differentiation of Human Acute Promyelocytic Leukemia HL-60 Cells. Biol Pharm Bull, 27: 1594-1598, 2004. [PubMe]